Companhia Siderúrgica Nacional Zukünftiges Wachstum

Future Kriterienprüfungen 3/6

Companhia Siderúrgica Nacional wird ein jährliches Gewinn- und Umsatzwachstum von 75.2% bzw. 2.2% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 28.8% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 13.8% betragen.

Wichtige Informationen

75.2%

Wachstumsrate der Gewinne

28.8%

EPS-Wachstumsrate

Metals and Mining Gewinnwachstum-0.07%
Wachstumsrate der Einnahmen2.2%
Zukünftige Eigenkapitalrendite13.8%
Analystenabdeckung

Good

Zuletzt aktualisiert15 Nov 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

With Companhia Siderúrgica Nacional (BVMF:CSNA3) It Looks Like You'll Get What You Pay For

Oct 23
With Companhia Siderúrgica Nacional (BVMF:CSNA3) It Looks Like You'll Get What You Pay For

Does Companhia Siderúrgica Nacional (BVMF:CSNA3) Have A Healthy Balance Sheet?

Sep 24
Does Companhia Siderúrgica Nacional (BVMF:CSNA3) Have A Healthy Balance Sheet?

With Companhia Siderúrgica Nacional (BVMF:CSNA3) It Looks Like You'll Get What You Pay For

Jun 02
With Companhia Siderúrgica Nacional (BVMF:CSNA3) It Looks Like You'll Get What You Pay For

Companhia Siderúrgica Nacional (BVMF:CSNA3) Seems To Be Using A Lot Of Debt

May 01
Companhia Siderúrgica Nacional (BVMF:CSNA3) Seems To Be Using A Lot Of Debt

Shareholders Should Be Pleased With Companhia Siderúrgica Nacional's (BVMF:CSNA3) Price

Feb 05
Shareholders Should Be Pleased With Companhia Siderúrgica Nacional's (BVMF:CSNA3) Price

Does Companhia Siderúrgica Nacional (BVMF:CSNA3) Have A Healthy Balance Sheet?

Jan 09
Does Companhia Siderúrgica Nacional (BVMF:CSNA3) Have A Healthy Balance Sheet?

Companhia Siderúrgica Nacional (BVMF:CSNA3) Seems To Be Using A Lot Of Debt

Oct 05
Companhia Siderúrgica Nacional (BVMF:CSNA3) Seems To Be Using A Lot Of Debt

Does Companhia Siderúrgica Nacional (BVMF:CSNA3) Have A Healthy Balance Sheet?

Jul 01
Does Companhia Siderúrgica Nacional (BVMF:CSNA3) Have A Healthy Balance Sheet?

Does Companhia Siderúrgica Nacional (BVMF:CSNA3) Have A Healthy Balance Sheet?

Mar 20
Does Companhia Siderúrgica Nacional (BVMF:CSNA3) Have A Healthy Balance Sheet?

Is Companhia Siderúrgica Nacional (BVMF:CSNA3) Using Too Much Debt?

Dec 02
Is Companhia Siderúrgica Nacional (BVMF:CSNA3) Using Too Much Debt?

We Think Companhia Siderúrgica Nacional (BVMF:CSNA3) Is Taking Some Risk With Its Debt

Aug 22
We Think Companhia Siderúrgica Nacional (BVMF:CSNA3) Is Taking Some Risk With Its Debt

Companhia Siderúrgica Nacional (BVMF:CSNA3) Could Become A Multi-Bagger

Aug 04
Companhia Siderúrgica Nacional (BVMF:CSNA3) Could Become A Multi-Bagger

Is Companhia Siderúrgica Nacional (BVMF:CSNA3) Using Too Much Debt?

Mar 31
Is Companhia Siderúrgica Nacional (BVMF:CSNA3) Using Too Much Debt?

We Think Companhia Siderúrgica Nacional (BVMF:CSNA3) Might Have The DNA Of A Multi-Bagger

Feb 01
We Think Companhia Siderúrgica Nacional (BVMF:CSNA3) Might Have The DNA Of A Multi-Bagger

Companhia Siderúrgica Nacional (BVMF:CSNA3) Seems To Use Debt Quite Sensibly

Dec 17
Companhia Siderúrgica Nacional (BVMF:CSNA3) Seems To Use Debt Quite Sensibly

Companhia Siderúrgica Nacional (BVMF:CSNA3) Is Achieving High Returns On Its Capital

Oct 13
Companhia Siderúrgica Nacional (BVMF:CSNA3) Is Achieving High Returns On Its Capital

Companhia Siderúrgica Nacional (BVMF:CSNA3) Has A Pretty Healthy Balance Sheet

Sep 01
Companhia Siderúrgica Nacional (BVMF:CSNA3) Has A Pretty Healthy Balance Sheet

Companhia Siderúrgica Nacional (BVMF:CSNA3) Is Looking To Continue Growing Its Returns On Capital

Jun 30
Companhia Siderúrgica Nacional (BVMF:CSNA3) Is Looking To Continue Growing Its Returns On Capital

Is Companhia Siderúrgica Nacional (BVMF:CSNA3) A Risky Investment?

May 19
Is Companhia Siderúrgica Nacional (BVMF:CSNA3) A Risky Investment?

What Do The Returns At Companhia Siderúrgica Nacional (BVMF:CSNA3) Mean Going Forward?

Mar 12
What Do The Returns At Companhia Siderúrgica Nacional (BVMF:CSNA3) Mean Going Forward?

Gewinn- und Umsatzwachstumsprognosen

BOVESPA:CSNA3 - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (BRL Millions)
DatumUmsatzGewinneFreier CashflowBargeld aus operativen TätigkeitenDurchschn. Anz. Analysten
12/31/202644,4411,269-7146,9977
12/31/202542,9911,726-4194,23510
12/31/202443,457658-5142,5933
9/30/202443,666-1,3801,7596,757N/A
6/30/202443,725-6942,3817,261N/A
3/31/202443,832181,6666,122N/A
12/31/202345,438-3182,8847,293N/A
9/30/202344,562-880-3155,550N/A
6/30/202344,334-592-7974,695N/A
3/31/202343,911-5791,0456,457N/A
12/31/202244,3621,554-3,3342,043N/A
9/30/202243,5942,4401473,469N/A
6/30/202242,9433,4572,2655,562N/A
3/31/202247,7698,2254,2867,478N/A
12/31/202147,91212,25911,92914,793N/A
9/30/202147,34515,08514,98117,446N/A
6/30/202145,81415,01613,78715,858N/A
3/31/202136,64310,39510,86212,565N/A
12/31/202030,0643,7947,8939,577N/A
9/30/202026,7941,1104,7416,698N/A
6/30/202024,086-9642,7524,915N/A
3/31/202024,7664361,8974,153N/A
12/31/201925,4361,7892,6564,872N/A
9/30/201924,9642,4652,4844,370N/A
6/30/201925,1224,1791,7283,336N/A
3/31/201923,9083,5951,5252,935N/A
12/31/201822,9695,0748892,208N/A
9/30/201821,9113,7119222,076N/A
6/30/201820,5553,216N/A1,860N/A
3/31/201819,1791,397N/A1,136N/A
12/31/201718,52510N/A572N/A
9/30/201718,050-427N/A596N/A
6/30/201717,710-744N/A516N/A
3/31/201717,563-54N/A1,111N/A
12/31/201617,149-925N/A276N/A
9/30/201616,283-1,301N/A3,426N/A
6/30/201615,747-1,742N/A3,160N/A
3/31/201615,249-2,394N/A2,392N/A
12/31/201515,262-1,216N/A5,069N/A
9/30/201515,429-693N/A1,641N/A
6/30/201515,379-411N/A1,585N/A
3/31/201515,766232N/A1,986N/A
12/31/201416,126-105N/A824N/A
9/30/201417,255-686N/A1,397N/A
6/30/201418,03464N/A1,821N/A
3/31/201418,041537N/A2,988N/A
12/31/201317,312509N/A2,198N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: CSNA3 wird in den nächsten 3 Jahren voraussichtlich rentabel werden, was als schnelleres Wachstum als die Sparquote angesehen wird (10.4%).

Ertrag vs. Markt: CSNA3 wird in den nächsten 3 Jahren voraussichtlich rentabel werden, was als überdurchschnittliches Marktwachstum angesehen wird.

Hohe Wachstumserträge: CSNA3 wird voraussichtlich in den nächsten 3 Jahren rentabel werden.

Einnahmen vs. Markt: CSNA3Die Einnahmen des Unternehmens (2.2% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt BR (7.4% pro Jahr).

Hohe Wachstumseinnahmen: CSNA3Die Einnahmen des Unternehmens (2.2% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.


Wachstumsprognosen für den Gewinn je Aktie


Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: CSNA3Die Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (13.8%).


Wachstumsunternehmen entdecken